Hormone Therapy News

In transgender women, estrogen therapy was shown to increase bone mineral density in both the lumbar spine and total hip during the first year of treatment, according to study findings presented at the European Congress of Endocrinology.

In children with growth hormone deficiency, C-peptide measurements provide a better estimate of insulin secretion than insulin levels throughout the first 12 months of growth hormone therapy, according to recent study findings.

Women who are younger than 60 years when they begin estradiol-based hormone therapy have a reduced risk for coronary heart disease mortality, according to study results.

Short-duration testosterone replacement therapy in older men was associated with increased risks for mortality and cardiovascular events, whereas longer duration therapy was associated with reduced mortality and cardiovascular events vs. matched controls, according to recent study findings.

Men with severe hypogonadism reported improved sexual function after testosterone replacement therapy with Nebido, study results show.

In male mice, androgen receptor deficiency in beta cells impairs glucose-stimulated insulin secretion, increasing the risk for developing type 2 diabetes, according to recent study findings.

Growth hormone therapy appears to yield height increases in children with Silver-Russell syndrome comparable to those gained by treated children without the disorder, according to recent findings.

Adults with growth hormone deficiency may need to maintain adequate levels of vitamin D to reach optimal effect of growth hormone therapy on bone quality, according to study findings.

BOSTON — Clinicians should avoid prescribing custom-compounded bioidentical hormones for the treatment of menopausal symptoms due to the potential risks and side effects the unregulated drugs carry, according to a new scientific statement issued by the Endocrine Society here.

BOSTON — In this video exclusive, Tamara Wexler, MD, PhD, director of the pituitary center at New York University Langone, give her perspective on the presentation involving results from the Testosterone Trials.